Kovack Advisors Inc. Grows Stock Holdings in Colgate-Palmolive (NYSE:CL)

Kovack Advisors Inc. increased its stake in Colgate-Palmolive (NYSE:CL) by 4.8% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 4,450 shares of the company’s stock after purchasing an additional 202 shares during the quarter. Kovack Advisors Inc.’s holdings in Colgate-Palmolive were worth $462,000 at the end of the most recent quarter.

A number of other large investors have also added to or reduced their stakes in the stock. Kingsview Wealth Management LLC boosted its stake in shares of Colgate-Palmolive by 10.0% during the 1st quarter. Kingsview Wealth Management LLC now owns 14,088 shares of the company’s stock worth $1,269,000 after acquiring an additional 1,285 shares during the last quarter. Dorsey & Whitney Trust CO LLC raised its stake in Colgate-Palmolive by 32.8% during the first quarter. Dorsey & Whitney Trust CO LLC now owns 3,635 shares of the company’s stock valued at $327,000 after purchasing an additional 898 shares in the last quarter. 1ST Source Bank bought a new position in shares of Colgate-Palmolive in the 1st quarter valued at about $201,000. Motco lifted its stake in shares of Colgate-Palmolive by 16.5% in the 1st quarter. Motco now owns 6,016 shares of the company’s stock valued at $542,000 after purchasing an additional 853 shares during the last quarter. Finally, Banco Santander S.A. boosted its stake in Colgate-Palmolive by 77.5% during the first quarter. Banco Santander S.A. now owns 19,319 shares of the company’s stock worth $1,740,000 after buying an additional 8,436 shares during the period. Institutional investors own 80.41% of the company’s stock.

Insiders Place Their Bets

In other Colgate-Palmolive news, Director Martina Hundmejean sold 2,313 shares of the company’s stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total value of $240,228.18. Following the completion of the sale, the director now directly owns 11,755 shares in the company, valued at $1,220,874.30. This represents a 16.44 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the sale, the chief financial officer now owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. The trade was a 55.29 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.34% of the stock is owned by company insiders.

Analysts Set New Price Targets

CL has been the subject of several recent analyst reports. Redburn Atlantic upgraded Colgate-Palmolive to a “hold” rating in a research report on Thursday, August 1st. StockNews.com raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating in a research report on Thursday. Stifel Nicolaus downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating and dropped their price objective for the company from $105.00 to $101.00 in a research report on Monday, October 28th. Morgan Stanley raised their target price on shares of Colgate-Palmolive from $103.00 to $111.00 and gave the company an “overweight” rating in a research note on Monday, July 29th. Finally, Deutsche Bank Aktiengesellschaft lowered Colgate-Palmolive from a “buy” rating to a “hold” rating and boosted their price target for the stock from $107.00 to $109.00 in a research note on Monday, September 9th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have issued a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $105.11.

Colgate-Palmolive Stock Up 0.4 %

Shares of CL opened at $91.44 on Friday. The stock’s 50 day moving average is $99.94 and its two-hundred day moving average is $98.48. Colgate-Palmolive has a 12 month low of $75.17 and a 12 month high of $109.30. The firm has a market cap of $74.71 billion, a P/E ratio of 26.20, a PEG ratio of 3.27 and a beta of 0.42. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46.

Colgate-Palmolive Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be paid a dividend of $0.50 per share. The ex-dividend date of this dividend is Friday, October 18th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.19%. Colgate-Palmolive’s dividend payout ratio is currently 57.31%.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.